BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32454163)

  • 1. Betel quid dependence mechanism and potential cessation therapy.
    Ko AM; Lee CH; Ko AM; Ko YC
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Dec; 103():109982. PubMed ID: 32454163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine oxidase A variants are associated with heavy betel quid use.
    Chen PH; Tu HP; Wang SJ; Ko AM; Lee CP; Chiang TA; Tsai YS; Lee CH; Shieh TY; Ko CH; Chiang SL; Ko YC
    Addict Biol; 2012 Jul; 17(4):786-97. PubMed ID: 21521428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cracking the Betel Nut: Cholinergic Activity of Areca Alkaloids and Related Compounds.
    Horenstein NA; Quadri M; Stokes C; Shoaib M; Papke RL
    Nicotine Tob Res; 2019 May; 21(6):805-812. PubMed ID: 29059390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intoxication and substance use disorder to Areca catechu nut containing betel quid: A review of epidemiological evidence, pharmacological basis and social factors influencing quitting strategies.
    Osborne PG; Ko YC; Wu MT; Lee CH
    Drug Alcohol Depend; 2017 Oct; 179():187-197. PubMed ID: 28787696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased functional connectivity in salience network is associated with symptom severity in betel quid-dependent chewers.
    Ban M; Zhan Z; Wang D; He J; Zhu X; Yuan F
    Addict Biol; 2023 Jan; 28(1):e13246. PubMed ID: 36577729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betel Nut (areca) and Smokeless Tobacco Use in Myanmar.
    Papke RL; Bhattacharyya I; Hatsukami DK; Moe I; Glatman S
    Subst Use Misuse; 2020; 55(9):1385-1394. PubMed ID: 31220988
    [No Abstract]   [Full Text] [Related]  

  • 7. Betel-quid dependence domains and syndrome associated with betel-quid ingredients among chewers: an Asian multi-country evidence.
    Lee CH; Chiang SL; Ko AM; Hua CH; Tsai MH; Warnakulasuriya S; Ibrahim SO; Sunarjo ; Zain RB; Ling TY; Huang CL; Lane HY; Lin CC; Ko YC
    Addiction; 2014 Jul; 109(7):1194-204. PubMed ID: 24650227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Betel Quid Addiction: A Review of Its Addiction Mechanisms and Pharmacological Management as an Emerging Modality for Habit Cessation.
    Sumithrarachchi SR; Jayasinghe R; Warnakulasuriya S
    Subst Use Misuse; 2021; 56(13):2017-2025. PubMed ID: 34396897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Betel quid: New insights into an ancient addiction.
    Stokes C; Pino JA; Hagan DW; Torres GE; Phelps EA; Horenstein NA; Papke RL
    Addict Biol; 2022 Sep; 27(5):e13223. PubMed ID: 36001424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinic Activity of Arecoline, the Psychoactive Element of "Betel Nuts", Suggests a Basis for Habitual Use and Anti-Inflammatory Activity.
    Papke RL; Horenstein NA; Stokes C
    PLoS One; 2015; 10(10):e0140907. PubMed ID: 26488401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Spontaneous Brain Activity in Betel Quid Dependence: A Resting-state Functional Magnetic Resonance Imaging Study.
    Liu T; Li JJ; Zhao ZY; Yang GS; Pan MJ; Li CQ; Pan SY; Chen F
    Medicine (Baltimore); 2016 Feb; 95(5):e2638. PubMed ID: 26844480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Executive function deficit in betel quid-dependence: Evidence from functional and effective connectivity of executive control network.
    Ban M; Wang D; He J; Zhu X; Yuan F
    Addict Biol; 2023 Nov; 28(11):e13341. PubMed ID: 37855074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and Functional Alterations in Betel-Quid Chewers: A Systematic Review of Neuroimaging Findings.
    Sariah A; Liu Z; Pu W; Liu H; Xue Z; Huang X
    Front Psychiatry; 2019; 10():16. PubMed ID: 30761025
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurological aspects of areca and betel chewing.
    Chu NS
    Addict Biol; 2002 Jan; 7(1):111-4. PubMed ID: 11900630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multivariate pattern analysis of resting-state functional MRI data in Naïve and chronic betel quid chewers.
    Linli Z; Huang X; Liu Z; Guo S; Sariah A
    Brain Imaging Behav; 2021 Jun; 15(3):1222-1234. PubMed ID: 32712800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered Spontaneous Brain Activity in Betel Quid Dependence Chewers: A Resting-State Functional MRI Study With Percent Amplitude of Fluctuation.
    Fu L; Chen H; Liu T; Liu L; Fu Q; Huang W; Chen F
    Front Psychiatry; 2022; 13():830541. PubMed ID: 35586413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of the pharmacokinetics of betel nut and betel quid biomarkers in saliva, urine, and hair of betel consumers.
    Franke AA; Li X; Lai JF
    Drug Test Anal; 2016 Oct; 8(10):1095-1099. PubMed ID: 26619803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Areca nut: a review.
    Arjungi KN
    Arzneimittelforschung; 1976; 26(5):951-6. PubMed ID: 786304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunction of the Prefrontal Cortex in Betel-Quid-Dependent Chewers.
    Kong L; Zeng C; Yuan F; Liu S; Wang D; Jiang C; Zhan Z; Qian Z; Zhu X
    Front Psychiatry; 2020; 11():558367. PubMed ID: 33192673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Motivates Betel Quid Chewers to Quit? An Analysis of Several Cessation-Relevant Variables.
    Aweau K; Erari S; Im S; Murphy K; Pokhrel P; Herzog TA
    Subst Use Misuse; 2024; 59(7):1095-1101. PubMed ID: 38403997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.